188 related articles for article (PubMed ID: 35251350)
1. Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid-based antisense: A potential new drug candidate for pancreatic cancer.
Shai A; Galouk E; Miari R; Tareef H; Sammar M; Zeidan M; Rayan A; Falah M
Oncol Lett; 2022 Apr; 23(4):130. PubMed ID: 35251350
[TBL] [Abstract][Full Text] [Related]
2. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide.
Cogoi S; Codognotto A; Rapozzi V; Meeuwenoord N; van der Marel G; Xodo LE
Biochemistry; 2005 Aug; 44(31):10510-9. PubMed ID: 16060660
[TBL] [Abstract][Full Text] [Related]
3. Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.
Itonaga M; Matsuzaki I; Warigaya K; Tamura T; Shimizu Y; Fujimoto M; Kojima F; Ichinose M; Murata S
PLoS One; 2016; 11(3):e0151654. PubMed ID: 26999437
[TBL] [Abstract][Full Text] [Related]
4. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
5. Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology.
Hatamoto M; Ohashi A; Imachi H
Appl Microbiol Biotechnol; 2010 Mar; 86(2):397-402. PubMed ID: 20135118
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
[TBL] [Abstract][Full Text] [Related]
7. Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [(64)Cu]DO3A-peptide nucleic acid-peptide nanoparticles.
Chakrabarti A; Zhang K; Aruva MR; Cardi CA; Opitz AW; Wagner NJ; Thakur ML; Wickstrom E
Cancer Biol Ther; 2007 Jun; 6(6):948-56. PubMed ID: 17611392
[TBL] [Abstract][Full Text] [Related]
8. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.
Shiraishi T; Nielsen PE
Artif DNA PNA XNA; 2011; 2(3):90-9. PubMed ID: 22567192
[TBL] [Abstract][Full Text] [Related]
9. Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors.
Sun L; Fuselier JA; Murphy WA; Coy DH
Peptides; 2002 Sep; 23(9):1557-65. PubMed ID: 12217415
[TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms involved in a low concentration of FL118 enhancement of AMR-MeOAc to induce pancreatic cancer cell apoptosis and growth inhibition.
Rabi T; Li F
Am J Cancer Res; 2018; 8(11):2267-2283. PubMed ID: 30555743
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of purine and pyrimidine-based
Park SY; Gowda Saralamma VV; Nale SD; Kim CJ; Jo YS; Baig MH; Cho J
Heliyon; 2024 Apr; 10(7):e28495. PubMed ID: 38617914
[TBL] [Abstract][Full Text] [Related]
12. Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nanoplatform.
Yu Z; Hu P; Xu Y; Bao Q; Ni D; Wei C; Shi J
Small; 2020 Jun; 16(23):e1907233. PubMed ID: 32406198
[TBL] [Abstract][Full Text] [Related]
13. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
14. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras.
Tian X; Chakrabarti A; Amirkhanov NV; Aruva MR; Zhang K; Mathew B; Cardi C; Qin W; Sauter ER; Thakur ML; Wickstrom E
Ann N Y Acad Sci; 2005 Nov; 1059():106-44. PubMed ID: 16382049
[TBL] [Abstract][Full Text] [Related]
15. Targeting RNA polymerase primary σ70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid.
Bai H; Sang G; You Y; Xue X; Zhou Y; Hou Z; Meng J; Luo X
PLoS One; 2012; 7(1):e29886. PubMed ID: 22253815
[TBL] [Abstract][Full Text] [Related]
16. Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions.
Shiraishi T; Eysturskarth J; Nielsen PE
BMC Cancer; 2010 Jun; 10():342. PubMed ID: 20591158
[TBL] [Abstract][Full Text] [Related]
17. Peptide nucleic acid (PNA) antisense effects in Escherichia coli.
Good L; Nielsen PE
Curr Issues Mol Biol; 1999; 1(1-2):111-6. PubMed ID: 11475695
[TBL] [Abstract][Full Text] [Related]
18. Peptide nucleic acids: Advanced tools for biomedical applications.
Gupta A; Mishra A; Puri N
J Biotechnol; 2017 Oct; 259():148-159. PubMed ID: 28764969
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
